Tolterodine Fumarate

富马酸托特罗定

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTolterodine Fumarate
Drug Alias Name托特药定托特罗宁
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsUrinary Bladder, Overactive
Approved Indications in ChinaUrinary Bladder, Overactive
Original Approved Country/TerritoryMainland China
Original Approved Date2005/12/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, Overactive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank